FDA approves RSV vaccine for older adults

FDA approves RSV vaccine for older adults

Upworthy

Published

The Food and Drug Administration on Wednesday approved Pfizer's vaccine against respiratory syncytial virus for people aged 60 and older, making it the second RSV shot authorized for use in the U.S. Why it matters: With the earlier approval of GlaxoSmithKline's RSV vaccine, older adults could soon…

#pfizer #rsv #glaxosmithkline #cdc #gsk #annaliesaanderson #fda #sanofi #astrazeneca

Full Article